Literature DB >> 10191243

Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis.

Z H Huang1, A Ferrante, R F Carter.   

Abstract

Free-living amoebae cause three well-defined disease entities: a rapidly fatal primary meningoencephalitis, a chronic granulomatous amoebic encephalitis (GAE), and a chronic amoebic keratitis. GAE occurs in immunocompromised persons. Recently, another type of free-living amoeba, Balamuthia mandrillaris, has been shown to cause GAE. The finding that this amoeba has caused infection in some healthy children has raised the possibility that humans may lack immunity to B. mandrillaris. Human serum was examined for the presence of surface antibodies specific for this amoeba by immunofluorescence. Sera from adults contained titers of 1/64-1/256 of anti-B. mandrillaris antibodies (IgM and IgG classes), which did not cross-react with other amoebae. Cord blood contained very low antibody levels, but levels similar to those in adults were seen in serum of 1- to 5-year-old children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191243     DOI: 10.1086/314731

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection.

Authors:  Francisco G Bravo; Carlos Seas
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Serologic survey for exposure following fatal Balamuthia mandrillaris infection.

Authors:  Brendan R Jackson; Zuzana Kucerova; Sharon L Roy; Glenda Aguirre; Joli Weiss; Rama Sriram; Jonathan Yoder; Rebecca Foelber; Steven Baty; Gordana Derado; Susan L Stramer; Valerie Winkelman; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2014-01-24       Impact factor: 2.289

3.  Diagnosis of first case of Balamuthia amoebic encephalitis in Portugal by immunofluorescence and PCR.

Authors:  Marta Tavares; Jose M Correia da Costa; S Stirling Carpenter; L A Santos; Caldas Afonso; Alvaro Aguiar; Josue Pereira; Ana Isabel Cardoso; Frederick L Schuster; Shigeo Yagi; Rama Sriram; Govinda S Visvesvara
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Identification of antigenic targets for immunodetection of Balamuthia mandrillaris infection.

Authors:  Zuzana Kucerova; Rama Sriram; Patricia P Wilkins; Govinda S Visvesvara
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

5.  Another case of canine amoebic meningoencephalitis--the challenges of reaching a rapid diagnosis.

Authors:  Priscilla J Hodge; Kylie Kelers; Robin B Gasser; Govinda S Visvesvara; Sandra Martig; Sam N Long
Journal:  Parasitol Res       Date:  2010-12-14       Impact factor: 2.289

Review 6.  Pathogenic free-living amoebae in Korea.

Authors:  Ho-Joon Shin; Kyung-il Im
Journal:  Korean J Parasitol       Date:  2004-09       Impact factor: 1.341

7.  Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain.

Authors:  Sharon L Roy; Jane T Atkins; Rosemaria Gennuso; Danny Kofos; Rama R Sriram; Thomas P C Dorlo; Teresa Hayes; Yvonne Qvarnstrom; Zuzana Kucerova; B Joseph Guglielmo; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2015-09-02       Impact factor: 2.289

Review 8.  Increasing importance of Balamuthia mandrillaris.

Authors:  Abdul Matin; Ruqaiyyah Siddiqui; Samantha Jayasekera; Naveed Ahmed Khan
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Assessment of Balamuthia mandrillaris-specific serum antibody concentrations by flow cytometry.

Authors:  Albrecht F Kiderlen; Elke Radam; Phiroze S Tata
Journal:  Parasitol Res       Date:  2008-11-28       Impact factor: 2.289

10.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.